Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILHEP: Intravenous Lidocaine in Open Hepatectomy
2025-522462-73-00Phase 4Authorised
- Sponsor
- CHU Rennes
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anesthesia complication comparing Perioperative intravenous lidocaine with Perioperative intravenous placebo (sodium chloride) (2 arms). Primary endpoint: Composite postoperative opioid-related adverse events within 48 hours. Planned start Mar 2026; status: authorised.
02
Drugs
lidocaine
03
Conditions
anesthesia complication
Beyond the preview
Go deeper on 2025-522462-73-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522462-73-00.